Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kartha

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Molecular Genetics and Metabolism Reports|December 18, 2020
Patients with Gaucher disease display systemic oxidative stress dependent on therapy statusReena V Kartha, Marcia R Terluk, Roland Brown, et al.
British Journal of Clinical Pharmacology|February 3, 2016
A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophyMariam A Ahmed, Reena V Kartha, Richard C Brundage, et al.
Pediatric Nephrology (Berlin, Germany)|February 3, 2025
Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in childrenDavid F G J Wolthuis, Jolien J M Freriksen, Mendy Ter Avest, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2026
Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophyChenxu Li, Kai Braaten, Ann B Moser, et al.
Journal of Psychiatry and Brain Science|May 26, 2021
Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young AdultsSiddhee A Sahasrabudhe, Thanharat Silamongkol, Young Woo Park, et al.
Bjpsych Open|September 22, 2025
Examination of oxidative stress and glutamate as potential mechanisms of N-acetylcysteine in the treatment of non-suicidal self-injury in young people assigned female at birth: randomised trialVictoria Papke, Bonnie Klimes-Dougan, Siddhee Anand Sahasrabudhe, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and EnablersMariam A Ahmed, Rajesh Krishna, Noha Rayad, et al.
Orphanet Journal of Rare Diseases|October 24, 2021
Development of therapies for rare genetic disorders of GPX4: roadmap and opportunitiesDorian M Cheff, Alysson R Muotri, Brent R Stockwell, et al.
Molecular Genetics and Metabolism|May 31, 2020
Gaucher disease and SARS-CoV-2 infection: Emerging management challengesPramod Mistry, Manisha Balwani, Deborah Barbouth, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Molecular Genetics and Metabolism Reports|December 18, 2020
Patients with Gaucher disease display systemic oxidative stress dependent on therapy statusReena V Kartha, Marcia R Terluk, Roland Brown, et al.
British Journal of Clinical Pharmacology|February 3, 2016
A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophyMariam A Ahmed, Reena V Kartha, Richard C Brundage, et al.
Pediatric Nephrology (Berlin, Germany)|February 3, 2025
Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in childrenDavid F G J Wolthuis, Jolien J M Freriksen, Mendy Ter Avest, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 8, 2026
Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophyChenxu Li, Kai Braaten, Ann B Moser, et al.
Journal of Psychiatry and Brain Science|May 26, 2021
Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young AdultsSiddhee A Sahasrabudhe, Thanharat Silamongkol, Young Woo Park, et al.
Bjpsych Open|September 22, 2025
Examination of oxidative stress and glutamate as potential mechanisms of N-acetylcysteine in the treatment of non-suicidal self-injury in young people assigned female at birth: randomised trialVictoria Papke, Bonnie Klimes-Dougan, Siddhee Anand Sahasrabudhe, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and EnablersMariam A Ahmed, Rajesh Krishna, Noha Rayad, et al.
Orphanet Journal of Rare Diseases|October 24, 2021
Development of therapies for rare genetic disorders of GPX4: roadmap and opportunitiesDorian M Cheff, Alysson R Muotri, Brent R Stockwell, et al.
Molecular Genetics and Metabolism|May 31, 2020
Gaucher disease and SARS-CoV-2 infection: Emerging management challengesPramod Mistry, Manisha Balwani, Deborah Barbouth, et al.
Pageof 5